Alembic Pharma

BSE : 533573 | NSE : APLLTD
Industry : Pharmaceuticals | ISIN : INE901L01018 | FreeFloat : 29.69% | FnO : No | LotSize : N/A
Intellectual Capital (IC)914.66
Net Worth (NW)5,244.98
Intrinsic Worth (IW)6,159.64
Market Cap (MC)11,261.10
Economic Value Added-67.20
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)14.85%
IC Gross Margin (EBITDA/IC)98.36%
IC Net Margin (NPT/IC)57.73%
Knowledge Turnover (Sales/IC)6.00
Market to Intrinsic Value (MC/IW)1.83
As OfIntrinsic ValueMarket Price
31 Dec 2022Rs. 313.37Rs. 572.90
20 Mar 2023 ---- Rs. 479.80
0.30     0.06%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 494.41AccumulateSell on Rallies
KB > 50% : No50 DMA : Rs. 525.04
0 < M2IV < 1 : NoVol-Price trend : Rising
Disclaimer: Stock outlook is based on data calculations only and does NOT constitute investment advice.

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-20
C
1206.83
1207.72
317.55
273.41
265.66
224.93
201.17
Jun-20
C
1341.32
1341.64
407.67
366.17
359.50
301.46
301.18
Sep-20
C
1457.10
1460.32
446.65
402.87
398.39
333.37
333.19
Dec-20
C
1314.33
1316.86
367.61
320.64
318.33
292.57
291.94
Mar-21
C
1280.39
1284.34
345.64
294.42
291.86
250.70
250.84
Jun-21
C
1326.03
1327.91
237.81
184.66
182.55
164.52
166.40
Sep-21
C
1292.32
1294.52
259.42
204.82
200.24
169.29
168.98
Dec-21
C
1271.70
1273.04
257.00
201.06
196.73
176.42
176.57
Mar-22
C
1415.74
1426.01
158.44
35.36
28.66
35.46
38.39
Jun-22
C
1262.14
1263.22
8.51
-58.59
-67.38
-65.88
-59.62
Sep-22
C
1475.01
1475.34
231.42
163.72
151.31
133.35
138.50
Dec-22
C
1509.02
1509.46
235.61
169.10
154.50
121.92
125.11
* C - Consolidated, S - Standalone